tiprankstipranks
Trending News
More News >
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market

Oncolytics Biotech (ONCY) Income Statement

Compare
1,246 Followers

Oncolytics Biotech Income Statement

Last quarter (Q4 2024), Oncolytics Biotech's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Oncolytics Biotech's net income was C$-8.02M. See Oncolytics Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ -403.00KC$ -392.00KC$ -452.06KC$ -446.19K
Operating Expenses
C$ 34.98MC$ 33.79MC$ 26.92MC$ 26.23MC$ 25.46M
Depreciation and Amortization
C$ 102.00KC$ 81.00KC$ 392.00KC$ 452.06KC$ 446.19K
EBITDA
C$ -34.88MC$ -33.71MC$ -26.83MC$ -25.80MC$ -25.37M
Operating Income
C$ -34.98MC$ -33.79MC$ -28.57MC$ -26.23MC$ -25.46M
Other Income/Expenses
C$ 3.40MC$ 6.14MC$ 2.17MC$ -20.05KC$ 2.95M
Pretax Income
C$ -31.58MC$ -27.66MC$ -24.75MC$ -26.25MC$ -22.51M
Net Income
C$ -31.71MC$ -27.75MC$ -24.84MC$ -26.30MC$ -19.55M
Per Share Metrics
Basic EPS
C$ -0.41C$ -0.41C$ -0.43C$ -0.49C$ -0.48
Diluted EPS
C$ -0.41C$ -0.41C$ -0.43C$ -0.49C$ -0.48
Weighted Average Shares Outstanding
76.48M 67.62M 58.03M 53.51M 40.34M
Weighted Average Shares Outstanding (Diluted)
76.48M 67.62M 58.03M 53.51M 40.34M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis